Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMC Samsung Volvo
you are here:

Tata India Pharma & Heathcare Fund - Direct Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : Tata Mutual Fund
  • NAV
    : ₹ 16.4537 1.21%
    (as on 25th January, 2021)
Crisil Rank

Not Ranked

Rank not available for the fund
Risk-O-Meter
High

Fund has 96.9% investment in indian stocks of which 48.49% is in large cap stocks, 24.82% is in mid cap stocks, 20.71% in small cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Nifty 50
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Nifty 50 : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 25th January, 2021)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 18-Jan-21 10125.40 1.25% - -0.19% 9/108
1 Month 24-Dec-20 10069.00 0.69% - 3.87% 100/107
3 Month 23-Oct-20 11260.80 12.61% - 20.40% 93/103
6 Month 24-Jul-20 13190.80 31.91% - 29.75% 33/101
YTD 01-Jan-21 9941.20 -0.59% - 2.20% 96/108
1 Year 24-Jan-20 16020.00 60.20% 59.79% 19.42% 9/99
2 Year 25-Jan-19 17775.90 77.76% 33.27% 16.05% 6/89
3 Year 25-Jan-18 17493.70 74.94% 20.47% 6.12% 7/75
5 Year 25-Jan-16 16734.20 67.34% 10.83% 13.55% 53/74
Since Inception 28-Dec-15 16453.70 64.54% 10.29% 14.53% 75/106

SIP Returns (NAV as on 25th January, 2021)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 24-Jan-20 12000 15941.56 32.85 % 65.53 %
2 Year 25-Jan-19 24000 36863.51 53.6 % 47.29 %
3 Year 25-Jan-18 36000 58462.55 62.4 % 34.07 %
5 Year 25-Jan-16 60000 101468.93 69.11 % 21.12 %
 

Tax Treatment

Portfolio (Updated on 31st Dec,2020)

Portfolio Turnover Ratio : 50.76%  |   Category average turnover ratio is 107.83%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 96.90% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 96.90%
No of Stocks : 23 (Category Avg - 33.15) | Large Cap Investments : 48.49%| Mid Cap Investments : 24.82% | Small Cap Investments : 20.71% | Other : 2.88%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Dr. Reddys Laboratories Ltd. Pharmaceuticals 560.1 13.36% -0.18% 17.99% (Mar 2020) 13.36% (Dec 2020) 1.08 L 0.00
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 408.8 9.75% 0.55% 17.08% (Jun 2020) 9.08% (Oct 2020) 6.90 L 0.00
Cipla Ltd. Pharmaceuticals 377.2 8.99% 0.06% 9.44% (Sep 2020) 0% (Jan 2020) 4.60 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 355.4 8.47% -0.22% 10.88% (Apr 2020) 8.21% (Oct 2020) 92.50 k 0.00
Narayana Hrudayalaya Ltd. Hospital 294.3 7.02% 0.71% 7.02% (Dec 2020) 0% (Jan 2020) 6.57 L 30.00 k
Ipca Laboratories Ltd. Pharmaceuticals 274.5 6.55% -0.53% 8.66% (Mar 2020) 6.03% (May 2020) 1.25 L 0.00
Alkem Laboratories Ltd. Hospital 261 6.22% 1.11% 6.22% (Dec 2020) 0% (Jan 2020) 89.20 k 20.20 k
Lupin Ltd. Pharmaceuticals 198.3 4.73% 0.01% 9.51% (Apr 2020) 4.72% (Nov 2020) 2.03 L 0.00
Procter & Gamble Health Ltd. Pharmaceuticals 177.3 4.23% -0.42% 6.88% (Jan 2020) 3.78% (Oct 2020) 26.00 k 0.00
Apollo Hospitals Enterprises Ltd. Hospital 170.1 4.06% -0.25% 6.51% (Feb 2020) 1.8% (Aug 2020) 70.50 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 3.37%
Net Receivables Net Receivables -0.27%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st December, 2020)

  • Standard Deviation

    High volatility
    18.4vs14.61
    Category Avg
  • Beta

    High volatility
    0.71vs0.61
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    0.85vs0.14
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.22vs0.04
    Category Avg
  • Jension's Alpha

    Better risk adjusted returns
    8.64vs-1.49
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
DSP Healthcare Fund - Direct Plan - Growth NA 1043.27 0.95 11.13 33.56 67.31 0.00
ICICI Prudential Technology Fund - Direct Plan - Growth NA 1184.58 4.91 19.16 57.06 65.64 26.03
Mirae Asset Healthcare Fund - Direct Plan - Growth NA 1209.93 -0.73 8.68 27.17 64.97 0.00
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Growth NA 2159.31 -0.11 11.48 28.52 64.71 0.00
Nippon India Pharma Fund - Direct Plan - Growth NA 4383.33 1.16 14.05 30.41 64.25 21.22
SBI Healthcare Opportunities Fund - Direct Plan - Growth NA 1575.33 2.27 13.54 33.26 63.91 16.32
Franklin India Technology Fund - Direct - Growth NA 471.85 9.29 21.64 45.47 61.06 25.89
UTI Healthcare - Direct Plan - Growth NA 649.26 -0.80 9.80 29.53 60.61 16.80
Aditya Birla Sun Life Digital India Fund - Direct Plan - Growth NA 861.20 6.21 19.48 50.58 56.12 24.90
Tata Digital India Fund - Direct Plan - Growth NA 812.53 7.18 19.36 51.39 55.85 26.71

More Funds from Tata Mutual Fund

Out of 58 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 10 is/are ranked 3 * , 4 is/are ranked 2 * , 4 is/are ranked 1 * , and 39 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Tata Liquid Fund - Direct Plan - Growth 3 19842.64 0.23 0.74 1.60 4.24 6.09
Tata Equity PE Fund - Direct Plan - Growth 3 4620.28 3.47 14.41 22.15 14.22 4.68
Tata Short Term Bond Fund - Direct Plan - Growth 3 3970.13 -0.03 1.00 2.45 9.78 6.87
Tata Hybrid Equity Fund - Direct Plan - Growth 2 3375.26 2.81 14.33 19.71 11.60 5.81
Tata Arbitrage Fund - Direct Plan - Growth 5 2813.81 0.34 0.98 2.08 5.45 0.00
Tata India Tax Savings Fund - Direct Plan - Growth 3 2480.85 4.02 18.96 27.60 13.74 7.20
Tata Large & Mid Cap Fund - Direct Plan - Appreciation 3 1934.09 2.38 17.14 23.04 12.37 7.81
Tata Multicap Fund - Direct Plan - Growth NA 1831.65 2.90 15.16 24.46 15.75 0.00
Tata Overnight Fund - Direct Plan - Growth NA 1785.79 0.26 0.75 1.53 3.28 0.00
Tata Treasury Advantage Fund - Direct Plan - Growth 3 1784.76 0.10 0.91 2.37 7.12 5.74

Forum

+ See More